MedTrace Logo

Use of N-Butyl Cyanoacrylate in Transarterial Emergency Embolization

NCT06301919 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 122

Last updated 2025-01-27

No results posted yet for this study

Summary

NBCA is a synthetic biodegradable cyanoacrylate basis glue, modified by the addition of a monomer with adhesive, hemostatic, and antiseptic properties.

Its use requires a steep learning curve to control emulsification of the NBCA/lipiodol mixture, and injection, to avoid non-target embolization.

The aim of this retrospective monocentric study was to evaluate safety and efficacy of use of NBCA as embolic agent in emergency setting.

Conditions

  • Haemostasis Embolisation

Interventions

OTHER

Clinical data

Collecting data from the medical record.

OTHER

Imaging data

Collecting data from the medical record.

OTHER

Biological data

Collecting data from the medical record.

Sponsors & Collaborators

  • Centre Hospitalier Universitaire de Saint Etienne

    lead OTHER

Principal Investigators

  • Rémi GRANGE, MD · CHU de Saint-Etienne

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-03-01
Primary Completion
2024-05-01
Completion
2024-05-01

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06301919 on ClinicalTrials.gov